224 related articles for article (PubMed ID: 25681438)
1. The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment.
Rayavarapu RR; Heiden B; Pagani N; Shaw MM; Shuff S; Zhang S; Schafer ZT
J Biol Chem; 2015 Apr; 290(14):8722-33. PubMed ID: 25681438
[TBL] [Abstract][Full Text] [Related]
2. ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells.
Khan IA; Yoo BH; Masson O; Baron S; Corkery D; Dellaire G; Attardi LD; Rosen KV
Oncogene; 2016 Nov; 35(44):5759-5769. PubMed ID: 27109096
[TBL] [Abstract][Full Text] [Related]
3. ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth.
Khan IA; Yoo BH; McPhee M; Masson O; Surette A; Dakin-Hache K; Younis T; Bethune G; Rosen KV
Breast Cancer Res; 2018 Dec; 20(1):151. PubMed ID: 30545388
[TBL] [Abstract][Full Text] [Related]
4. ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.
Malin D; Strekalova E; Petrovic V; Rajanala H; Sharma B; Ugolkov A; Gradishar WJ; Cryns VL
Oncogene; 2015 Nov; 34(45):5626-34. PubMed ID: 25684139
[TBL] [Abstract][Full Text] [Related]
5. ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells.
Grassian AR; Schafer ZT; Brugge JS
J Biol Chem; 2011 Jan; 286(1):79-90. PubMed ID: 20956544
[TBL] [Abstract][Full Text] [Related]
6. ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth.
Liu X; Chipurupalli S; Jiang P; Tavasoli M; Yoo BH; McPhee M; Mazinani S; Francia G; Kerbel RS; Rosen KV
Cell Death Dis; 2022 Aug; 13(8):687. PubMed ID: 35933456
[TBL] [Abstract][Full Text] [Related]
7. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
[TBL] [Abstract][Full Text] [Related]
8. First trimester human placenta prevents breast cancer cell attachment to the matrix: The role of extracellular matrix.
Epstein Shochet G; Drucker L; Pomeranz M; Fishman A; Pasmanik-Chor M; Tartakover-Matalon S; Lishner M
Mol Carcinog; 2017 Jan; 56(1):62-74. PubMed ID: 26859229
[TBL] [Abstract][Full Text] [Related]
9. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia/HIF1α induces lapatinib resistance in ERBB2-positive breast cancer cells via regulation of DUSP2.
Karakashev SV; Reginato MJ
Oncotarget; 2015 Feb; 6(4):1967-80. PubMed ID: 25596742
[TBL] [Abstract][Full Text] [Related]
11. Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies.
Surette A; Yoo BH; Younis T; Matheson K; Rameh T; Snowdon J; Bethune G; Rosen KV
Breast Cancer Res Treat; 2021 Jun; 187(3):743-758. PubMed ID: 33728523
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment.
Schafer ZT; Grassian AR; Song L; Jiang Z; Gerhart-Hines Z; Irie HY; Gao S; Puigserver P; Brugge JS
Nature; 2009 Sep; 461(7260):109-13. PubMed ID: 19693011
[TBL] [Abstract][Full Text] [Related]
13. HPW-RX40 restores anoikis sensitivity of human breast cancer cells by inhibiting integrin/FAK signaling.
Chen IH; Shih HC; Hsieh PW; Chang FR; Wu YC; Wu CC
Toxicol Appl Pharmacol; 2015 Dec; 289(2):330-40. PubMed ID: 26386190
[TBL] [Abstract][Full Text] [Related]
14. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
Asp N; Pust S; Sandvig K
Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
[TBL] [Abstract][Full Text] [Related]
15. The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance.
Whelan KA; Schwab LP; Karakashev SV; Franchetti L; Johannes GJ; Seagroves TN; Reginato MJ
J Biol Chem; 2013 May; 288(22):15865-77. PubMed ID: 23585570
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic Ras differentially regulates metabolism and anoikis in extracellular matrix-detached cells.
Mason JA; Davison-Versagli CA; Leliaert AK; Pape DJ; McCallister C; Zuo J; Durbin SM; Buchheit CL; Zhang S; Schafer ZT
Cell Death Differ; 2016 Aug; 23(8):1271-82. PubMed ID: 26915296
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
18. The regulation of cancer cell death and metabolism by extracellular matrix attachment.
Buchheit CL; Rayavarapu RR; Schafer ZT
Semin Cell Dev Biol; 2012 Jun; 23(4):402-11. PubMed ID: 22579674
[TBL] [Abstract][Full Text] [Related]
19. Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestration.
Buchheit CL; Angarola BL; Steiner A; Weigel KJ; Schafer ZT
Cell Death Differ; 2015 Aug; 22(8):1275-86. PubMed ID: 25526094
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin regulates anoikis resistance via cell aggregate formation.
Han HJ; Sung JY; Kim SH; Yun UJ; Kim H; Jang EJ; Yoo HE; Hong EK; Goh SH; Moon A; Lee JS; Ye SK; Shim J; Kim YN
Cancer Lett; 2021 Jun; 508():59-72. PubMed ID: 33771684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
